Incyte CEO on New Drugs, Jakafi Applications

Incyte CEO on New Drugs, Jakafi Applications Play

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

blog comments powered by Disqus